December 18, 2017 / 5:15 PM / a month ago

BRIEF-Mauna Kea Receives FDA Clearance For Cellvizio 100 Series

Dec 18 (Reuters) - MAUNA KEA TECHNOLOGIES SAS:

* NEW FDA CLEARANCE VALIDATES IN VIVO, REAL-TIME “IDENTIFICATION OF CELLULAR AND VASCULAR ORGANIZATION AND ARCHITECTURE” USING CELLVIZIO®

* ‍PIVOTAL REGULATORY MILESTONE POSITIONING CELLVIZIO AS UNIQUE REAL-TIME IN VIVO VISUALIZATION SYSTEM​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below